引用本文:苗迎秋,李志,高文仓.阿霉素诱导的卵巢癌耐药细胞P-糖蛋白的表达[J].大连医科大学学报,2010,32(1):35-39+44.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载 本文二维码信息
码上扫一扫!
分享到: 微信 更多
阿霉素诱导的卵巢癌耐药细胞P-糖蛋白的表达
苗迎秋1, 李志2, 高文仓3
1.大连大学 医学院 药理学教研室,辽宁 大连 116622;2.大连市中心医院 检验科,辽宁 大连 116033;3.大连大学 新华医院 肿瘤科,辽宁 大连 116021
摘要:
[目的]探讨mdr1基因编码的P-糖蛋白(mdr1/P-gp)在阿霉素(ADR)诱导的卵巢癌多药耐药细胞中的作用。[方法]MTT法检测药物对敏感细胞株(SK-OV-3)和诱导的耐药细胞株(SK-OV-3/adr)的半数致死浓度(IC50),计算耐药指数(RI)和加逆转剂后的逆转倍数,荧光显微镜观察不同时间细胞内的药物含量变化,荧光分光光度法测定细胞内ADR的含量,RT-PCR和Western blot法检测细胞耐药前后mdr1/P-gp的变化。[结果]对阿霉素、长春新碱、紫杉醇和足叶乙甙,SK-OV-3/adr细胞株的IC50 均有明显增加,RI分别为58.4、122.6、41.0和43.7,逆转倍数分别为20.5、66.9、11.3和18.1。30、60、120 min SK-OV-3细胞株ADR含量分别是SK-OV-3/adr细胞株的3.7[(191.9±1.7)/(51.7±6.3)ng/mL]、5.9[(285.3±4.0)/(48.2±2.8)ng/mL]和8.6[(447.8±1.3)/(52.0±1.8)ng/mL]倍,二者比较差异有非常显著性意义(P<0.01)。P-gp竞争性逆转剂(Ver)作用30、60、120 min后SK-OV-3/adr细胞ADR含量提高了1.6、2.7和5.1倍,与逆转前相比差异有非常显著性意义(P<0.01)。RT-PCR和Western blot结果显示SK-OV-3/adr细胞mdr1/P-gp均表达阳性,SK-OV-3细胞mdr1/P-gp表达阴性。[结论]mdr1/P-gp在ADR诱导的SK-OV-3/adr细胞多药耐药机制中起重要作用。
关键词:  卵巢肿瘤  多药耐药  mdr1/P-gp
DOI:10.11724/jdmu.2010.01.09
分类号:R73-36
基金项目:
Expression of P-glycoprotein induced by adriamycin in multidrug resistance cells of ovarian cancer
MIAO Ying-qiu1, LI Zhi2, GAO Wen-cang3
1.Medical College, Dalian University, Dalian 116622, China;2.Department of Clinical Laboratory, Dalian Central Hospital, Dalian 116033, China;3.Department of Oncology, Xinhua Hospital of Dalian University, Dalian 116021, China
Abstract:
[Objective] To investigate the effect of P-glucoprotein (mdr1/P-gp) encoded by mdr1 gene on drug resistant cells of ovarian cancer induced by Adriamycin(ADR).[Methods] MTT assay was employed to test the lethal concentration 50 (IC50) of sensitive germline (SK-OV-3) and ovarian cancer cell subline induced by ADR (SK-OV-3/adr) treated by 4 drugs, resistance index and reverse multiple were calculated. The changes of drug content were observed by fluorescence microscope, the intracellular accumulation of ADR was evaluated by fluorospectrophotometry, the changes of mdr 1/P-gp resistance were observed respectively by RT-PCR and Western blot.[Results] After treatment of Adriamycin, Vincristine, Paclitaxel and Etoposide, the IC50 of SK-OV-3/adr increased significantly, the resistance indexes (RIs) were 58.4, 122.6, 41.0 and 43.7, respectively. ADR contents of SK-OV-3 detected by fluorospectrophotometry in 30min, 60min and 120 min were 3.7, 5.9, 8.6 times, respectively (SK-OV-3 vs SK-OV-3/adr, P<0.01). After treated by P-gp competively reverse agent (Ver) in 30 min, 60 min and 120 min ADR contents of SK-OV-3/adr were 1.6, 2.7 and 5.1 times higher (P<0.01). The mdr 1/P-gp expression of SK-OV-3/adr cell was observed by RT-PCR and Western blot, but lost in SK-OV-3 cell.[Conclusion] mdr1/P-gp plays a role in the multidrug resistance of SK-OV-3/adr cell induced by ADR.
Key words:  ovarian cancer  multidrug resistance  mdr1/P-gp